Olink Holding Ab Publ Quick Ratio (OLK) starting from the fourth quarter 2023 to fourth quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Olink Holding Ab publ   (NASDAQ: OLK)

Olink Holding Ab Publ 's Quick Ratio

OLK's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2023, Quick Ratio deteriorated to 2.18 below Olink Holding Ab Publ 's average Quick Ratio.

Within Laboratory Analytical Instruments industry 8 other companies have achieved higher Quick Ratio than Olink Holding Ab Publ in fourth quarter 2023. While Quick Ratio total ranking in the fourth quarter 2023 has deteriorated compared to the prior quarter from 833 to 1116.

Explain Quick Ratio?
How much Cash & cash equivalents OLK´s has?
What are OLK´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OLK Quick Ratio (Dec 31 2023)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Dec 31 2022)
Q4
Y / Y Current Liabilities Change 53.76 % 53.76 % 53.76 % 53.76 % 14.26 %
Y / Y Cash & cash equivalent Change 61.04 % 61.04 % 61.04 % 61.04 % -36.4 %
Quick Ratio MRQ 2.18 2.18 2.18 2.18 2.08
OLK's Total Ranking # 1116 # 833 # 839 # 839 # 1355
Seq. Current Liabilities Change 0 % 0 % 0 % 53.76 % 0 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % 61.04 % 0 %



Quick Ratio fourth quarter 2023 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 9
Healthcare Sector # 499
Overall Market # 1116


Quick Ratio Statistics
High Average Low
3.74 2.67 2.08
(Dec 31 2021)   (Dec 31 2022)




Financial Statements
Olink Holding Ab Publ 's Current Liabilities $ 55 Millions Visit OLK's Balance sheet
Olink Holding Ab Publ 's Cash & cash equivalent $ 121 Millions Visit OLK's Balance sheet
Source of OLK's Sales Visit OLK's Sales by Geography


Cumulative Olink Holding Ab Publ 's Quick Ratio

OLK's Quick Ratio for the trailling 12 Months

OLK Quick Ratio

 (Dec 31 2023)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Dec 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 53.76 % 44.84 % 35.32 % 25.16 % 14.26 %
Y / Y Cash & cash equivalent TTM Growth 61.04 % 27.53 % 1.48 % -19.36 % -36.4 %
Quick Ratio TTM 2.18 2.16 2.14 2.11 2.08
Total Ranking TTM # 3821 # 3830 # 3834 # 3151 # 3711
Seq. Current Liabilities TTM Growth 9.58 % 10.59 % 11.85 % 13.44 % 3.22 %
Seq. Cash & cash equivalent TTM Growth 10.47 % 11.69 % 13.24 % 15.26 % -12.52 %

Quick ratio ranking by company, industry and sector >> Back to OLK Financial Strength Comparisons >> Go to Compare OLK Quick Ratio to its Competitors

On the trailing twelve months basis OLK Cash & cash equivalent soared by 61.04 % in Q4 2023 year on year, faster than Current Liabilities, this led to increase in in Olink Holding Ab Publ 's Quick Ratio to 2.18, Quick Ratio remained below OLK average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 22 other companies have achieved higher Quick Ratio than Olink Holding Ab Publ . While Quick Ratio overall ranking has improved so far to 3821, from total ranking during the twelve months ending third quarter 2023 at 3830.

Explain Quick Ratio?
How much Cash & cash equivalents OLK´s has?
What are OLK´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 23
Healthcare Sector # 965
Within the Market # 3821


trailing twelve months Quick Ratio Statistics
High Average Low
3.74 2.68 2.08
(Dec 31 2021)   (Dec 31 2022)




Companies with similar Quick Ratio in the quarter ending Dec 31 2023, within Laboratory Analytical Instruments Industry Quick RatioDec 31 2023 MRQ Cash & cash equivalentDec 31 2023 MRQ Current Liabilities
10x Genomics Inc   5.59 $ 388.883  Millions$ 69.567  Millions
Eyepoint Inc   5.31 $ 336.050  Millions$ 63.263  Millions
Bionano Genomics Inc   4.34 $ 101.888  Millions$ 23.460  Millions
Akoya Biosciences Inc   3.87 $ 83.125  Millions$ 21.471  Millions
Waters Corporation  2.46 $ 396.898  Millions$ 161.078  Millions
Olink Holding Ab publ   2.18 $ 120.957  Millions$ 55.487  Millions
Bio rad Laboratories Inc   2.09 $ 735.075  Millions$ 350.891  Millions
Cue Health Inc   1.86 $ 80.889  Millions$ 43.466  Millions
Lifeloc Technologies Inc   1.85 $ 1.767  Millions$ 0.954  Millions
Agilent Technologies inc   1.26 $ 1,590.000  Millions$ 1,262.000  Millions
Prenetics Global Limited  1.16 $ 45.706  Millions$ 39.484  Millions
Accelerate Diagnostics Inc   1.10 $ 13.219  Millions$ 12.034  Millions
Standard Biotools Inc   0.99 $ 114.895  Millions$ 116.266  Millions
Revvity Inc  0.90 $ 1,603.079  Millions$ 1,789.219  Millions
Precipio inc   0.56 $ 1.502  Millions$ 2.681  Millions

Date modified: 2026-09-08T15:11:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.